Activity of selenium on cell proliferation, cytotoxicity, and apoptosis and on the expression of CASP9, BCL-XL and APC in intestinal adenocarcinoma cells

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 715, Issue 1-2, 2011, Pages 7-12

  Mauro, M O ^a   Sartori, Daniele ^b   Oliveira, Rodrigo Juliano ^c   Ishii, Priscila Lumi ^a   Mantovani, Mário Sérgio ^b   Ribeiro, Lúcia Regina ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b STATE UNIVERSITY OF LONDRINA   (Brazil)

^c FEDERAL UNIVERSITY OF MATO GROSSO DO SUL   (Brazil)

Author keywords

Gene expression; Oligoelement; RNA; Selenium

Indexed keywords

DOXORUBICIN; SELENOMETHIONINE;

APC GENE; APOPTOSIS; ARTICLE; BCL XL GENE; CASP9 GENE; CELL PROLIFERATION; CELL STRAIN HT29; CONTROLLED STUDY; DRUG CYTOTOXICITY; GADPH GENE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION;

ADENOCARCINOMA; ADENOMATOUS POLYPOSIS COLI PROTEIN; APOPTOSIS; BCL-X PROTEIN; CASPASE 9; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DOXORUBICIN; DRUG SYNERGISM; GENE EXPRESSION; HT29 CELLS; HUMANS; SELENIUM; SELENOMETHIONINE;

EID: 81155159692     PISSN: 00275107     EISSN: 09218262     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2011.06.015     Document Type: Article

References (52)

1. Fogg-johnson N., Kaput J. Nutrigenomics: an emerging scientific discipline. Food Technol. 2003, 57:60-67.
2. Kaput J., Noble J., Hatipoglu B., Kohrs K., Dawson K.K., Bartholomew A. Application of nutrigenomic concepts to type 2 diabetes mellitus. Nutr. Metab. Cardiovasc. 2007, 17:89-103.
3. Hesketh J. Nutrigenomics and selenium: gene expression patterns, physiological targets, and genetics. Annu. Rev. Nutr. 2009, 28:157-177.
4. Ferrari C.K.B., Torres E.A.F.S. Novos compostos dietéticos com propriedades anticarcinogênicas. Revista Brasileira de Cancerologia 2002, 48:375-382.
5. Flagg E.W., Coates R.J., Greenberg R.S. Epidemiologic studies of antioxidants and cancer in humans. J. Am. Coll. Nutr. 1995, 14:419-427.
6. Weisburger J.H. Colon carcinogens: their metabolism and mode of action. Cancer 2001, 28:60-69.
7. Reddi A.S., Bollineni J.S. Selenium-deficient diet induces renal oxidative stress and injury via TGF-beta 1 in normal and diabetic rats. Kidney Int. 2001, 59:1342-1353.
8. Combs G.F., Gray P.G. Chemopreventive agents: selenium. Pharmacol. Ther. 2006, 79:179-192.
9. Hesketh J. Nutrigenomics and selenium: gene expression patterns, physiological targets, and genetics. Annu. Rev. Nutr. 2008, 28:157-177.
10. Jackson M.I., Combs G.F. Selenium and anticarcinogenesis: underlying mechanisms. Micronutrients 2008, 11:718-726.
11. Albanes D. Vitamin supplements and cancer prevention: where do randomized controlled trials stand?. JNCI 2009, 101:2-4.
12. Chakraborty P., Hossain U., Bhattacharya S. Chemoprotection and enhancement of cancer chemotherapeutic efficacy of cyclophosphamide in mice bearing Ehrlich ascites carcinoma by diphenylmethyl selenocyanate. Cancer Chemother. Pharmacol. 2009, 11:76-88.
13. Peng X., Cui Y., Cui W., Deng J., Cui H. The decrease of relative weight, lesions, and apoptosis of bursa of fabricius induced by excess dietary selenium in chickens. Biol. Trace Elem. Res. 2009, 10:90-100.
14. Schomburg L., Dumitrescu M.A., Liao X.H., Bin-abbas B., Hoeflich J., Köhrle J., Refetoff S. Selenium supplementation fails to correct the selenoprotein synthesis defect in subjects with SBP2 gene mutations. Thyroid 2009, 19:277-281.
15. Wallace K., Kelsey K.T., Schned A., Morris J.S., Andrew A.S., Karagas M.R. Selenium and risk of bladder cancer: a population-based case-control study. Cancer Prev. Res. 2009, 2:70-73.
16. Sutherland A.M., Kim D.H., Relton C., Ahn Y.O., Hesketh J. Polymorphisms in the selenoprotein S and 15-kDa selenoprotein genes are associated with altered susceptibility to colorectal cancer. Genes Nutr. 2010, 15:215-223.
17. Stevens R.G., Swede H., Rosenberg D.W. Epidemiology of colonic aberrant crypt focci: review and analysis of existing studies. Cancer Lett. 2006, 32:123-128.
18. Pienta K.J., Partin A.W., Coffey D.S. Cancer as a disease of DNA organization and dynamic cell structure. Cancer Res. 1989, 49:2525-2532.
19. Bos J.L., Kreijil C.F. Genes and genes products that regulate proliferation: critical targets in carcinogenesis. IARC Sci. Publ. 1992, 116:57-65.
20. Pitot H.C. The molecular biology of carcinogenesis. Cancer 1993, 72:962-967.
21. Kerr J.R.F., Winterford C.M., HARMON B.V. Its significance in cancer and cancer therapy. Cancer 1994, 73:2013-2026.
22. Pool-zobel B., Van Loo J., Rowland I., ROBERFROID M.B. Experimental evidences on the potential of prebiotic fructans to reduce the risk of colon cancer. Br. J. Nutr. 2002, 87:S273-S281.
23. Buddington K.K., Donahoo J.B., Bubbington R.K. Dietary oligofructose and inulin Protect mice from enteric and systemic pathogens and tumor inducers. J. Nutr. 2007, 132:472-477.
24. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation cytotoxic assays. J. Immunol. Methods 1983, 65:55-63.
25. Rovozzo G.C., Burke C.N. A Manual of Basic Virological Techniques 1973, 14. Prentice Hall, New Jersey, 159.
26. Pfaffl M.W., Horgan G.W., Dempfle L. Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 2002, 30:2-10.
27. Suzuki M., Endo G., Manabu T., Shinohara F., Echigo S., Rikiishi H. Differential apototic response of human cancer cells to organoselenium compounds. Cancer Chemother. Pharmacol. 2009, 22:43-50.
28. Borges L.P., Nogueira C.W., Rocha J.B.T., Zeni G. Acute liver damage induced by 2-nitrpropane in rats: effect of diphenyl diselenide on antioxidant defenses. Chem. Biol. Interact. 2006, 160(2):99-107.
29. Rikiishi H. Apoptotic cellular events for selenium compounds involved in cancer prevention. J. Bioenerg. Biomembr. 2007, 39:91-98.
30. Zeng H., Combs G.F., J.R. Selenium as an anticancer nutrient: roles in cell proliferation and tumor cell invasion. J. Nutr. Biochem. 2007, 19:7-11.
31. Narayanan B.A., Narayanan N.K., Desai D., Pittman B., Reddy B.S. Effects of a combination of docosahexaenoic acid and 1,4-phenylene bis(methylene) selenocyanate on cyclooxygenase 2, inducible nitric oxide synthase and β-catenin pathways in colon cancer cells. Carcinogenesis 2004, 25:2443-2449.
32. Rudolf E., Rudolf K., Červinka M. Selenium activates p53 and p38 pathways and induces caspase-independent cell death in cervical cancer cells. Cell Biol. Toxicol. 2008, 24:123-141.
33. Jariwalla R.J., Gangapurkar B., Nakamura D. Differential sensitivity of various human tumour-derived cell types to apoptosis by organic derivatives of selenium. Br. J. Nutr. 2009, 101:182-189.
34. Reagen-shaw S., Nihal M., Ahsan H., Mukhtar H., Ahmad N. Combination of vitamin E and selenium causes an induction of apoptosis of human prostate cancer cells by enhancing Bax/Bcl-2 ratio. Prostate 2008, 68:1624-1634.
35. Cao Z., Wu L.P., Li Y.X., Guo Y.B., Chen Y.W., Wu R.H. Change of choline compounds in sodium selenite-induced apoptosis of rats used as quantitative analysis by in vitro 9.4T MR spectroscopy. World J. Gastroenterol. 2008, 14:3891-3896.
36. Guan L., Huang F., Li Z., Han B., Jiang Q., Ren Y.Y., Y.A.N.G., C.X.U. P53 transcription-independent activity mediates selenite-induced acute promyelocytic leukemia NB4 cell apoptosis. BMB Rep. 2008, 34:745-750.
37. Jung U., Zheng X., Yoon S.O., Chung A.S. Se-ethylselenocysteine induces apoptosis mediated by reactive oxygen species in hl-60 cells. Free Radic. Biol. Med. 2001, 31:479-489.
38. Yeo J.K., Cha S.D., Cho C.H., Kim S.P., Cho J.W., Baek W.K., Suh M.H., Kwon T.K., Park J.W., Suh S.I. Se-methylselenocysteine induces apoptosis through caspase activation and Bax cleavage mediated by calpain in SKOV-3 ovarian cancer cells. Cancer Lett. 2002, 182:83-92.
39. Sheng J., Cui W.J., Fu L., Jin P., Han Y., Li S.J., Fan R.Y., Li A.Q., Zhang M.Z., Li S.R. APC gene mutations in Chinese familial adenomatous polyposis patients. World J. Gastroenterol. 2010, 28:1522-1526.
40. Bienz M., Hamada F. Adenomatous polyposis coli proteins and cell adhesion. Curr. Opin. Cell Biol. 2004, 16:528-535.
41. Aoki K., Taketo M.M. Adenomatous polyposis coli (APC): a multifunctional tumor suppressor gene. J. Cell Sci. 2007, 120(2007):3327-3335.
42. Davis C.D., Zeng H., Finley J.W. Selenium-enriched broccoli decreases intestinal tumorigenesis in multiple intestinal neoplasia mice. J. Nutr. 2002, 132:307-309.
43. Parolin M.B., Reasson R.J. Apoptose como mecanismo de lesão nas doenças hepatobiliares. Arq Gastroenterol. 2001, 38:138-144.
44. Liu Y., Zhang X. Expression of cellular Oncogene Bcl-xL prevents coronavirus-induced cell death and converts acute infection to persistent infection in progenitor rat oligodendrocytes. J. Virol. 2005, 79:47-56.
45. Zhang X., Zarbl H. Chemopreventive doses of methylselenocysteine alter circadian rhythm in rat mammary tissue. Cancer Prev. Res. 2008, 1:119-127.
46. Yang Y., Huang F., Ren Y., Xing L., Wu Y., Li Z., Pan H., Xu C. The anticancer effects of sodium selenite and selenomethionine on human colorectal carcinoma cell lines in nude mice. Oncol. Res. 2009, 18:p.1-p.8.
47. Zimmer A.S. Perfil imunohistoquímico das proteínas da família BCL-2 e evolução clínica do câncer de ovário: uma análise de pacientes do Hospital de Clínicas de Porto Alegre/Brasil. Dissertação de Mestrado. Pós-graduação em ciências médicas da Universidade Federal do Rio Grande do Sul 2007.
48. Sinha R., El-bayoumy K. Apoptosis is a critical cellular event in cancer chemoprevention and chemotherapy by selenium compounds. Curr. Cancer Drug Targets 2004, 4:13-28.
49. Ghibelli L., Coppola S., Rotilio G., Lafavia E., Maresca V., Ciriolo M.R. Non-oxidative loss of glutathione in apoptosis via GSH extrusion. Biochem. Biophys. Res. Commun. 1995, 216:313-320.
50. Kaplowitz N. Cell death at the millennium. Implications for liver diseases. Clin. Liver Dis. 2000, 4(2000):1-23.
51. Mcconkey D.J. Biochemical determinants of apoptosis and necrosis. Toxicol. Lett. 1998, 157-168.
52. Carvalho G.D. Estudo in vitro da apoptose induzida em linfócitos de camundongos BALB/c imunizados com o peptídio sintético anticarrapato Rhipicephalus (Boophilus) microplus (SBm 7462) por via oral e nasal. Viçosa, Dissertação (mestrado). Universidade Federal de Viçosa 2008, 122 pp.